# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T15:46:34.236770
**Route:** OpenRouter + LaTeX
**Paper Hash:** fae4deb0fb19b7a7
**Tokens:** 18117 in / 1262 out
**Response SHA256:** d65a581e4a1d5aa4

---

## Fatal-error audit (pre-submission)

### 1) Data–Design Alignment (CRITICAL)

- **Treatment timing vs. data coverage:** Your analysis sample is **2015–2019 and 2021–2023** (2020 excluded). Treatment cohorts are **2019–2023**, with “not-yet-treated” 2024 adopters (AZ/AR/KY). This is **feasible**: max(treatment year) = 2023 ≤ max(data year) = 2023.
- **Post-treatment observations by cohort:**  
  - 2019 cohort has post observations in **2019, 2021–2023** (4 post periods given 2020 missing).  
  - 2020 cohort has post observations in **2021–2023** (3).  
  - 2021 cohort has post observations in **2021–2023** (3).  
  - 2022 cohort has post observations in **2022–2023** (2).  
  - 2023 cohort has post observations in **2023 only** (1).  
  This satisfies the basic requirement that treated cohorts have post-treatment data (including the 2023 cohort, which is necessarily short).
- **Treatment definition consistency:** Treatment-year coding described in the Data section matches Appendix Table `tab:crown_dates` and the cohort counts used elsewhere. No contradiction found.

**No fatal data–design misalignment detected.**

---

### 2) Regression Sanity (CRITICAL)

Checked all regression tables present in the draft:

- **Table 2 (`tab:main_results`)**: coefficients and SEs are in plausible ranges for gaps in rates/shares and log earnings. No SE explosions; no coefficients of impossible magnitude. Adjusted \(R^2\) values are between 0 and 1.
- **Table 3 (`tab:sex_heterogeneity`)**: SEs and CIs are plausible; no impossible statistics.
- **Table 4 (`tab:robustness`)**: no impossible values; SEs plausible; no NA/NaN/Inf.

**No fatal regression-output problems detected.**

---

### 3) Completeness (CRITICAL)

- **No placeholders** (TBD/TODO/NA/XXX) in tables or results.
- **Regression tables report N (Observations)** and standard errors.
- **All referenced tables/figures appear to exist in the LaTeX source** (they are referenced and have labels/captions). I cannot verify external PDF figure files compile-time availability from the source alone, but there is no *internal* missing-reference evidence in the text (e.g., referencing a non-existent label).

**No fatal completeness issues detected.**

---

### 4) Internal Consistency (CRITICAL)

- Counts/timing are consistent: “22 by 2023” matches the adoption-date table (22 entries through 2023) and the cohort structure used throughout.
- Treatment/control definitions are consistent (never-treated through 2023 include the three 2024 adopters).
- Reported key estimates in text match Table `tab:main_results` (employment gap ATT \(\approx -0.003\); triple-diff customer-facing \(0.0128\), etc.).

**No fatal internal inconsistencies detected.**

---

ADVISOR VERDICT: PASS